Recently Viewed

News Announcement

Glenmark Pharmaceuticals: Announcement under Regulation 30 (LODR)-Change in Management

29-May-2026 Follow Value Research Online on Google download pdfDownload PDF Glenmark Pharmaceuticals

The Board at its meeting held today i.e. May 29 2026 have approved Early Retirement of Company Secretary & Compliance Officer Appointment of Company Secretary & Compliance Officer and Appointment of Senior Management Personnel.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.